In Alzheimer’s disease and related tauopathies, trans-synaptic transfer and accumulation of pathological tau from donor to recipient neurons is thought to contribute to disease progression, but the underlying mechanisms are poorly understood. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.